| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/02/2008 | WO2008049226A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
| 05/02/2008 | WO2008030557A3 Compositions and methods for enhancing transport through mucus |
| 05/02/2008 | WO2008010864A3 Modified adenovirus hexon protein and uses thereof |
| 05/02/2008 | WO2008002470A3 Sirna sequences against brf1 |
| 05/02/2008 | WO2006026570A3 Use of stem cells to generate inner ear cells |
| 05/02/2008 | CA2667582A1 Method of treating conditions associated with proteoglycan production |
| 05/02/2008 | CA2666981A1 Soluble tnf receptors and their use in treatment of disease |
| 05/02/2008 | CA2666346A1 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
| 05/01/2008 | US20080103108 Targeted artificial gene delivery |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080103095 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 05/01/2008 | US20080103092 Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances |
| 05/01/2008 | US20080102524 Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity |
| 05/01/2008 | US20080102508 Formulation of adenovirus for gene therapy |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102057 Bipotential liver cell lines from wild-type mammalian liver tissue |
| 05/01/2008 | US20080102054 Aorta gonad mesoderm composition for use in treatment of nervous system, blood, inflammatory, autoimmune, skin, respiratory and liver disorders |
| 04/30/2008 | EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses |
| 04/30/2008 | EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 04/30/2008 | EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9; |
| 04/30/2008 | EP0983351B1 Nucleic acid binding proteins |
| 04/30/2008 | EP0983350B1 Nucleic acid binding proteins |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | DE102006050655A1 Pharmaceutical composition useful for treating allergic diseases comprises RNA and an allergen |
| 04/30/2008 | CN101168742A Oncolytic virus and its preparing method |
| 04/30/2008 | CN101168741A Lactococcus lactis food-sate secretion expression carrier and its preparing method and application |
| 04/30/2008 | CN101168594A Polyglycol active derivative with oligopeptide as framework, preparation method thereof and conjugate of the same and pharmaceutical molecule |
| 04/30/2008 | CN101168065A Recombination archaea histone HPhA as gene medicine carrier and application in preparing anti-cancer medicine |
| 04/30/2008 | CN101168064A Recombination human pancreatic cancer mucus protein core peptide DNA vaccine |
| 04/30/2008 | CN101168063A Spring viremia of carp virus DNA vaccine and preparation method thereof |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384865C Methods and composition for therapeutic use of RNA interference |
| 04/30/2008 | CN100384481C Blastocyst implantation related factor and its uses |
| 04/30/2008 | CN100384480C Delivery system for nucleic acids |
| 04/29/2008 | US7365175 Wit 3.0, a novel gene to control soft tissue wound healing |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 04/29/2008 | US7365058 Diabetes; DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA |
| 04/29/2008 | US7364894 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/29/2008 | US7364887 Osteoarthritis; rheumatic diseases; antiarthritic agents |
| 04/29/2008 | US7364871 screening for candidates that modulate interaction of MEKK and MIF1 comprising a) contacting MIF1 protein with MEKK protein and a candidate molecule, and b) detecting modulation of the interaction of MIF1 and MEKK; antagonists or agonists of MIF1/MSP58-MEKK1 binding |
| 04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364750 Gene expression cassettes; transcription |
| 04/29/2008 | US7364740 Genetic deletions are used as markers to distinguish between pathogenic and avirulent strains such as Mycobacterium and Bacillus Calmette-Guerin (BCG); immunoassay; vaccines; attenuation, genetic engineering; immunogenic pure polypeptide encoded by a nucleotide sequence comprising open reading frame |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364727 Transcriptional regulatory element (TRE) sequence operably linked to virus replication gene; adenoviral vectors; selective cytotoxicity |
| 04/29/2008 | US7364726 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine |
| 04/29/2008 | CA2294756C Cross-linked polysaccharide drug carrier |
| 04/29/2008 | CA2259960C Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/24/2008 | WO2008049113A2 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 04/24/2008 | WO2008048976A2 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/24/2008 | WO2008048685A2 Ox40 aptamers |
| 04/24/2008 | WO2008048680A2 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/24/2008 | WO2008048298A2 Polymer particles for delivery of macromolecules and methods of use |
| 04/24/2008 | WO2008048272A2 Method of drug delivery by carbon nanotube-chitosan nanocomplexes |
| 04/24/2008 | WO2008048057A1 Myonectin and uses thereof |
| 04/24/2008 | WO2008047904A1 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/24/2008 | WO2008047574A1 Sensitizer for anticancer agent |
| 04/24/2008 | WO2008046943A1 Transposon hsmar2 and use thereof in the generation of vectors that can be used in somatic gene therapy |
| 04/24/2008 | WO2008016629A3 Novel glutamic acid decarboxylase (gad) proteins and methods of use |
| 04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
| 04/24/2008 | WO2007124106A8 Application of antl-apoptotic genes in mammalian cells for perfusion culture. |
| 04/24/2008 | WO2007117472A3 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells |
| 04/24/2008 | US20080097090 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/24/2008 | US20080097087 Micelles; complexes; stability; MALDI-TOF-MS |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096808 co-administering the protein replacement therapy with rapamycin, to inhibiting the immune response of a host to protein replacement therapy; immunology modulators |
| 04/24/2008 | US20080096793 Class III Slrp for the Treatment of Cancer |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095820 Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
| 04/24/2008 | US20080095817 Template having thereon at least one synthetic degradable extracellular matrix layer and one biomolecule releasably associated with layer, biomolecule comprising cell-affecting portion and matrix-binding portion; temporally controlling growth factor signaling and directing activities of associated cells |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095798 Ii-key enhanced vaccine potency |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095746 Using cells expressing podocalyxin-like protein 1 (PCLP1) as source for propagating progenitor cells for use in treatment of blood and vascular diseases; regenerative medicine |
| 04/24/2008 | US20080095743 Using immunoglobulins to identify and isolate skeletal-based precursor of cardiomyocytes (Spoc) for use in treatment of nervous system disorders |
| 04/24/2008 | US20080095742 Composition for Treating Virus Infection Disease Comprising Jab1 |
| 04/24/2008 | US20080095709 Method and apparatus for installation of dental implant |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914305A1 GSK3 polypeptides |
| 04/23/2008 | EP1913957A1 Adjuvanted genetic vaccines |
| 04/23/2008 | EP1912680A2 Her-2 peptides |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1912678A2 Use of an active biological substance in abnormal cellular and viral membrane physiologies |